December 19, 2018

Accenture Awarded US Patent for Combining Classical and Quantum Computing With Potential to Address Previously Unsolvable Business Problems

NEW YORK; Dec. 19, 2018 – Accenture (NYSE: ACN) has been granted a US patent for a “multi-state quantum optimization engine” that leverages quantum computing technology to help organizations optimize business decision making with unprecedented efficiency and effectiveness.

Quantum computing has the potential to solve complex business problems millions of times faster than classical computing by leveraging the properties of quantum physics to process multiple computing tasks in parallel. Accenture’s new patent — U.S. Patent No. 10,095,981 — reveals how businesses could take advantage of the best aspects of both classical and quantum computing techniques to enable breakthrough solutions to problems that couldn’t be solved before.

Accenture’s patent describes an optimization engine that helps organizations identify a broader range of solutions to business challenges. By running multiple simulations at the same time, the optimal outcome can be identified, improving business decision-making and operational efficiency. For example,

“We recognize the significant potential that quantum computing has to fundamentally disrupt how organizations across industries operate, and we’re committed to actively helping to shape the future for how it’s applied to create business value,” said Paul Daugherty, Accenture’s chief technology & innovation officer. “Our quantum computing optimization engine patent is the latest example of how we’re strategically investing in and harnessing this technology to deliver tangible results.”

The patent is one of the most recent in Accenture’s robust global intellectual property portfolio and builds on years of quantum investments, partnerships and R&D efforts. For example, earlier this year Accenture joined a worldwide community of partners working to advance quantum computing, enabling Accenture to rapidly scale its quantum programs and better connect with organizations that are pushing the boundaries in this field. In 2017 Accenture entered into a strategic alliance with 1QBit, a leading quantum computing firm, and the two collaborated with Biogen to develop a first-of-its-kind quantum-enabled molecular comparison application to exponentially speed up drug discovery.

“In rapidly shifting markets, companies need to be able to predict their next best action both quickly and precisely,”said Narendra Mulani, chief analytics officer, Accenture Applied Intelligence. “Integrating both classical and quantum computing devices could allow organizations to run simulations at a massive scale to determine best possible outcomes. It’s a truly visionary concept — clients can apply it to solving optimization tasks from a wide range of applications, such as machine learning, information security, pattern recognition, image analysis, and bioinformatics.”

The patent for the multi-state quantum optimization engine was co-invented by Andy Fano, managing director at Accenture Labs; Dan Garrison, managing director at Accenture Digital; and Jurgen Weichenberger, managing director at Accenture Applied Intelligence.

To learn more about Accenture and its quantum computing work, please visit www.accenture.com/quantum.

About Accenture
Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions — underpinned by the world’s largest delivery network — Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With 459,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at www.accenture.com.

# # #

Contact:

Hannah Unkefer
Accenture
+1 206 839 2172
hannah.m.unkefer@accenture.com

Copyright © 2018 Accenture. All rights reserved. Accenture and its logo are trademarks of Accenture.